HBS, Aldrich Hall

Over two days of panel discussions, presentations, and networking, our distinguished speakers will provide insights – as well as guardrails – for navigating the emerging industry of regenerative medicine. We will explore how advances in cell and gene therapy, drug development, and bioengineering in regenerative medicine are moving from the lab to the patient - and what it will take to identify real, lasting value for business and society.